New Tx Approach for Immunotherapy-Induced Myocarditis
A novel combination of high-dose abatacept, ruxolitinib, and mechanical ventilation markedly improved immunotherapy-induced myocarditis survival over current guideline-recommended treatment.
Medscape Medical News
source https://www.medscape.com/viewarticle/988928?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/988928?src=rss
Comments
Post a Comment